Zaki Salanti

Senior Director, Head of Search & Evaluation at Novo Nordisk A/S

Speaker

Zaki Salanti is since 2018 Director in Search and Evaluation, Global Business Development at Novo Nordisk. He was previously Director toxicology at Novo Nordisk. Zaki joined Novo Nordisk in 2005.

Zaki has been responsible for the scouting and coordination of evaluation of external innovation in cardiovascular and kidney disease. Besides innovative therapies, the Search and Evaluation team sources and evaluate a broad range of technologies, including new drug delivery systems and protein engineering. Zaki was recently appointed Head of the Search and Evaluation department.